Skip to content

Jobs updated Oct 23, 6:25 AM CT

COMPANY

Nelum Pharma

HQ: Cary, NC source · nelumpharma.com ↗

Clinical Phase 2

Location: Cary, NC · source · Oct 14, 2026

Profile checked Oct 10, 2026

Keywords: Untreated Advanced Pancreatic Cancer Pancreatic Ductal Adenocarcinoma NLM-001

2Trials (company is sponsor)

Timeline

Jul 15, 2026 Trial start Phase 2: A Clinical Study Evaluating a New Treatment Strategy for Patients With Advanced Pancreatic Cancer Who Have Not Received Prior Treatment for Advanced Disease. source ↗
Sep 1, 2021 Trial start Phase 1/Phase 2: Study to Evaluate the Safety and Efficacy of Treatment With NLM-001 and Standard Chemotherapy Plus Zalifrelimab in Patients With Advanced Pancreatic Cancer source ↗

Upcoming milestones

Feb 28, 2029 (ESTIMATED) · Phase 2 · A Clinical Study Evaluating a New Treatment Strategy for Patients With Advanced Pancreatic Cancer Who Have Not Received Prior Treatment for Advanced Disease. · NCT07578337

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 2

Record	Title	Phase	Status	Start	Primary completion
NCT07578337	A Clinical Study Evaluating a New Treatment Strategy for Patients With Advanced Pancreatic Cancer Who Have Not Received Prior Treatment for Advanced Disease.	Phase 2	Not yet recruiting	Jul 15, 2026	Feb 28, 2029 (estimated)
NCT04827953	Study to Evaluate the Safety and Efficacy of Treatment With NLM-001 and Standard Chemotherapy Plus Zalifrelimab in Patients With Advanced Pancreatic Cancer	Phase 1/Phase 2	Active, not recruiting	Sep 1, 2021	2025-04 (estimated)